Skip to main content
. Author manuscript; available in PMC: 2010 Aug 17.
Published in final edited form as: Curr Opin Chem Biol. 2008 Jan 25;12(2):197–206. doi: 10.1016/j.cbpa.2007.11.013

Figure 1.

Figure 1

Metal-based anticancer drugs that primarily target DNA. (a) Pt(iv) complexes that deliver cisplatin and two equivalents of estradiol (1) and the GST inhibitor ethacrynic acid (2) after activation. (b) Photolabile platinum diazide complexes 4 and 5 demonstrate good cytotoxicity upon irradiation. (c) Typical, cytotoxic examples of the ruthenium- and osmium-arene family of complexes.